-
ACADIA Pharmaceuticals (NASDAQ:ACAD) Receives Overweight Rating from Cantor Fitzgerald
Source: Buzz FX / 28 Feb 2025 11:01:14 America/Chicago
ACADIA Pharmaceuticals (NASDAQ:ACAD) Receives Overweight Rating from Cantor Fitzgerald Written by MarketBeat February 28, 2025 Share Link copied to clipboard. ACADIA Pharmaceuticals ( NASDAQ:ACAD - Get Free Report ) 's stock had its "overwe
Read more...